background
object
metereddos
inhal
plu
spacer
mdispac
effect
better
nebul
aerosol
deliveri
select
aerosol
deliveri
system
hospit
children
signific
impact
util
healthcar
resourc
design
set
qualiti
improv
project
evalu
impact
convers
mdispac
administ
bronchodil
bd
inhal
corticosteroid
icss
hospit
children
util
hospit
resourc
project
conduct
tertiari
pediatr
ward
april
may
materi
method
project
conduct
sixweek
period
first
two
week
data
gather
hospit
children
receiv
bd
andor
icss
nebul
data
collect
follow
twoweek
washout
period
train
healthcar
provid
oper
chang
implement
enhanc
convers
mdispac
last
two
week
data
gather
hospit
children
convers
mdispac
primari
outcom
includ
mean
time
minut
medic
prepar
deliveri
secondari
outcom
includ
follow
need
respiratori
therapi
assist
estim
cost
treatment
session
patientcaregiv
satisfact
result
five
hundr
seventyf
treatment
session
enrol
nebul
mdispac
nebul
group
male
predomin
slightli
older
compar
mdispac
group
male
vs
mean
age
vs
month
respect
durat
treatment
prepar
deliveri
significantli
lower
mdispac
group
min
reduct
prepar
time
min
reduct
deliveri
time
p
caregiv
master
mdispac
use
averag
two
observ
session
elimin
need
respiratori
therapi
assist
hospit
stay
medic
cost
analysi
show
save
favor
mdispac
cost
reduct
per
dose
albuterol
ipratropium
bromid
icss
patient
satisfact
survey
show
good
excel
level
group
conclus
convers
mdispac
bd
icss
administr
hospit
children
improv
hospit
resourc
util
inhal
therapi
repres
prefer
mode
deliveri
asthma
medic
nebul
medic
solut
spacer
metereddos
inhal
mdi
among
wide
use
modal
sever
studi
shown
mdispac
effect
better
nebul
aerosol
deliveri
children
nebul
use
requir
power
suppli
take
time
conveni
portabl
gener
expens
requir
mainten
need
supervis
contrast
spacer
easier
use
requir
less
effort
time
requir
dose
prepar
electr
deliveri
portabl
requir
lower
medic
dose
compar
nebul
nebul
also
signific
impact
infect
control
use
nebul
associ
major
outbreak
sever
acut
respiratori
syndrom
sar
hong
kong
march
hospit
use
nebul
hospit
children
requir
addit
resourc
term
cost
human
resourc
respiratori
therapist
requir
supervis
treatment
session
despit
fact
nebul
still
wide
use
modal
choic
administ
bronchodil
bd
inhal
corticosteroid
icss
hospit
children
asthma
guidelin
includ
recent
publish
saudi
initi
asthma
sina
guidelin
recommend
use
spacer
children
even
younger
yr
old
aim
studi
investig
impact
convers
mdispac
administ
bd
icss
hospit
children
util
hospit
resourc
treatment
prepar
deliveri
time
need
respiratori
therapi
assist
cost
qualiti
improv
project
conduct
evalu
impact
inhal
devic
select
hospit
children
util
hospit
resourc
treatment
prepar
deliveri
time
need
respiratori
therapi
assist
cost
project
conduct
tertiari
pediatr
ward
king
faisal
specialist
hospit
research
centr
aprilemay
ultim
goal
studi
come
evidencebas
practic
polici
inhal
therapi
minim
unnecessari
wast
hospit
resourc
without
neg
impact
patient
care
studi
intend
compar
pharmacolog
efficaci
new
intervent
nebul
mdispac
licens
use
children
studi
review
regist
qualiti
improv
project
organ
qualiti
improv
board
inclus
criteria
hospit
children
requir
bd
andor
icss
age
year
presenc
caregiv
exclus
criteria
uncoop
patient
sick
patient
requir
shift
intens
care
unit
unavail
caregiv
project
conduct
period
week
first
week
data
gather
hospit
children
receiv
bd
andor
icss
nebul
follow
washout
period
train
healthcar
provid
oper
chang
implement
enhanc
convers
mdispac
last
week
data
gather
hospit
children
convers
mdispac
primari
outcom
includ
mean
time
minut
medic
prepar
deliveri
secondari
outcom
includ
need
respiratori
therapi
assist
estim
cost
treatment
session
patientcaregiv
satisfact
devic
instruct
provid
caregiv
involv
patient
care
follow
data
collect
everi
treatment
session
prepar
time
deliveri
time
medic
name
dosag
mode
deliveri
oxygen
flow
rate
nebul
therapi
assess
sheet
use
determin
minimum
number
session
supervis
respiratori
therapist
requir
ensur
caregiv
compet
use
mdispac
patientcaregiv
satisfact
survey
perform
part
qualiti
assur
measur
routin
collect
respiratori
therapist
hospit
medic
devic
cost
estim
base
inform
provid
hospit
pharmaci
respiratori
therapi
depart
respect
medic
observ
includ
bronchodil
albuterol
ipratropium
bromid
inhal
corticosteroid
fluticason
budesonid
combin
longact
bronchodil
ic
fluticasonesalmeterol
mdiequival
dosag
bd
icss
solut
develop
see
tabl
target
collect
data
treatment
session
part
two
project
phase
nebul
phase
mdispac
phase
minimum
observ
event
addit
descript
data
analysi
student
ttest
use
compar
mean
prepar
deliveri
time
two
group
statist
signific
set
p
five
hundr
seventyf
treatment
session
enrol
nebul
spacer
tabl
show
demograph
characterist
group
nebul
group
male
predomin
compar
spacer
group
averag
age
children
month
children
nebul
group
slightli
older
mean
age
month
rang
month
compar
spacer
group
mean
age
month
rang
month
prescrib
medic
follow
albuterol
ic
combin
ipratropium
bromid
other
nebul
group
mean
time
treatment
prepar
min
ci
min
mean
time
treatment
deliveri
min
ci
mdispac
group
mean
time
treatment
prepar
min
ci
min
mean
time
treatment
deliveri
min
ci
min
see
tabl
result
indic
replac
nebul
mdispac
shorten
time
medic
prepar
time
deliveri
time
min
differ
prepar
time
min
deliveri
time
p
caregiv
master
mdispac
use
averag
supervis
session
result
convers
mdispac
lead
independ
treatment
administr
patientscaregiv
signific
impact
resourc
util
organ
mandat
nebul
session
supervis
respiratori
therapist
patient
satisfact
survey
show
stabl
good
excel
level
phase
studi
medic
cost
reduct
analysi
show
cost
reduct
per
dose
follow
albuterol
ipratropium
bromid
icss
favor
mdispac
take
account
cost
medic
spacer
nebul
kit
studi
demonstr
import
role
qualiti
improv
project
implement
evidencebas
practic
optim
util
hospit
resourc
studi
result
indic
need
hospit
polici
modif
enhanc
convers
mdispac
deliveri
method
choic
bd
icss
whenev
applic
hospit
children
believ
lead
better
util
hospit
resourc
without
neg
affect
pharmacolog
effect
medic
fact
simpl
practic
chang
lead
wiser
util
respiratori
therapist
time
effort
util
import
aspect
patient
care
extrem
import
especi
signific
shortag
respiratori
therapist
across
hospit
global
cost
save
also
expect
result
lower
cost
medic
elimin
need
nebul
machin
dispos
nebul
kit
prevent
unnecessari
use
oxygen
treatment
importantli
reduc
need
cost
respiratori
therapist
overtim
shift
although
save
theoret
plausibl
lack
solid
evid
confirm
assumpt
note
convers
mdispac
might
rais
concern
increas
cost
due
spacer
expens
might
valid
concern
devic
provid
patient
longterm
use
minim
use
nebul
might
health
benefit
relat
decreas
airborn
spread
infecti
agent
signific
effect
inpati
care
pediatr
hospit
might
signific
infect
control
impact
howev
knowledg
investig
pediatr
popul
studi
shown
asthmat
children
use
mdispac
nebul
bronchodil
administr
emerg
depart
result
similar
clinic
respons
shorter
durat
stay
lower
incid
tachycardia
even
lower
rate
admiss
one
studi
infant
age
month
random
doubl
blind
trial
compar
mdispacerto
nebulizeradminist
albuterol
wheez
episod
emerg
depart
patient
spacer
group
significantli
lower
admiss
rate
versu
nebul
group
receiv
fewer
treatment
lower
mean
increas
heart
rate
less
like
receiv
steroid
lower
admiss
rate
spacer
group
found
primarili
children
sever
asthma
exacerb
anoth
random
doubleblind
placebocontrol
trial
emerg
depart
children
hospit
includ
children
year
age
moder
sever
acut
asthma
spacer
effect
nebul
term
clinic
score
respiratori
rate
oxygen
satur
produc
greater
reduct
wheez
p
z
heart
rate
increas
greater
degre
nebul
group
min
vs
spacer
p
fewer
children
spacer
group
requir
admiss
vs
nebul
group
p
z
adjust
sex
differ
observ
rate
tremor
hyperact
interestingli
studi
show
cost
save
spacer
group
cost
benefit
report
studi
american
adult
document
annual
cost
save
asthma
therapi
substitut
spacer
nebul
metaanalysi
systemat
review
show
patient
receiv
betaagonist
mdispac
show
signific
decreas
admiss
rate
compar
nebul
ci
p
z
decreas
even
signific
among
children
moder
sever
exacerb
ci
p
z
addit
measur
sever
eg
clinic
score
significantli
improv
group
receiv
betaagonist
mdispac
comparison
receiv
nebul
treatment
standard
mean
differ
ci
p
z
convers
mdispac
might
encount
difficulti
lack
awar
healthcar
practition
patient
andor
caregiv
disbelief
nebul
effect
shortag
proper
size
type
spacer
need
effect
patient
educ
ensur
proper
devic
use
canadian
studi
nation
survey
barrier
mdispac
use
pediatr
emerg
depart
reveal
mdispac
infrequ
use
treat
patient
acut
asthma
canadian
pediatr
emerg
depart
despit
fact
emerg
staff
believ
effect
largest
perceiv
barrier
mdispac
implement
includ
concern
regard
safeti
cost
feasibl
provid
steril
spacer
parent
expect
use
nebul
barrier
includ
staff
belief
regard
effect
mdispac
chang
nurs
workload
lack
physician
champion
chang
report
us
children
hospit
strategi
implement
convers
mdispac
show
increas
spacer
use
among
nonintensivecar
patient
receiv
albuterol
among
patient
asthma
p
strategi
includ
follow
distinct
intervent
plan
implement
convers
program
literatur
review
product
select
polici
oper
chang
staff
train
studi
show
chang
patient
andor
caregiv
satisfact
convers
mdispac
australian
studi
major
parent
found
easi
easi
use
spacer
report
intend
use
spacer
home
major
children
said
prefer
use
spacer
quicker
easier
use
anoth
studi
young
patient
children
parent
prefer
spacer
convers
mdispac
administr
bronchodil
inhal
corticosteroid
hospit
children
led
reduct
treatment
prepar
deliveri
time
enabl
earli
independ
administr
patientcaregiv
addit
potenti
reduct
medic
cost
qualiti
improv
project
indic
select
inhal
devic
major
impact
resourc
util
hospit
studi
requir
investig
impact
strategi
hospit
length
stay
differ
set
eg
emerg
depart
